eMedicine Specialties > Ophthalmology > Retina

Lattice Degeneration

Author: David Sarraf, MD, Assistant Clinical Professor of Ophthalmology, Jules Stein Eye Institute, University of California at Los Angeles, Greater Los Angeles Veterans Affairs Healthcare System
Coauthor(s): Stanley M Saulny, MD, Consulting Staff, Department of Ophthalmology, Ophthalmology Associates of the Valley
Contributor Information and Disclosures

Updated: Feb 27, 2007

Introduction

Background

Lattice degeneration is a common, atrophic disease of the peripheral retina characterized by oval or linear patches of retinal thinning. The prevalence peaks by the second decade and is believed to be minimally progressive but may be uncommonly complicated by retinal detachment.

Pathophysiology

The pathogenesis of lattice degeneration is not well understood, although several theories have been proposed. Regional developmental absence of the internal limiting membrane versus abnormal vitreoretinal traction dynamics appears to be the most cogent argument proposed.

Frequency

United States

Lattice degeneration affects approximately 10% of the population and is bilateral in 30-50% of patients who are affected. A variable familial risk may be present on the basis of various autosomal dominant pedigrees. An increased prevalence exists in myopic eyes, and its prevalence may be associated with increasing axial length, reaching 15% in the longest eyes.

International

No information is available regarding the international occurrence of lattice degeneration.

Mortality/Morbidity

See discussion of retinal detachment in History and Physical.

Race

No reported racial differences exist in lattice degeneration.

Sex

No reported sex differences exist in lattice degeneration.

Age

See History regarding early onset and progression with age.

Clinical

History

Patients with lattice degeneration are typically asymptomatic, and the lesions are usually an incidental finding of dilated ophthalmologic examination. A presenting complaint of blurriness in the distance may be the result of myopia, a common association of lattice degeneration. The acute onset of floaters, flashes of light, peripheral field loss, or central vision loss may indicate the presence of a retinal tear or detachment, a complication of lattice lesions.

Physical

  • Clinical features
    • Lattice degeneration is characterized by oval or linear patches of atrophic retina with a reddish base and is variably located within the equatorial region of the fundus, typically inferotemporal.
    • Lesions may be isolated or multifocal, variable in dimension, and usually are oriented concentric or slightly oblique to the ora serrata.
    • Condensed vitreous at the margins of the lattice lesions may appear as vitreous opacities and represent regions of increased vitreoretinal adhesion; overlying vitreal opacities alternatively may be explained by glial proliferation.
    • Crisscrossing fine white lines that account for the name lattice degeneration are present in roughly only 10% of lesions and most likely represent hyalinized blood vessels.
    • Various pigmentary disturbances occur in more than 80% of lattice lesions. White-yellow flecks, similar to that seen with degenerative retinoschisis, are an additional common associated feature.
    • Atrophic retinal holes and tractional retinal tears may complicate lattice degeneration and increase the risk of retinal detachment.
  • Clinical variations
    • Snail-track degeneration is a morphologic descriptive term for retinal lesions with the same characteristic size, shape, orientation, and location as lattice lesions and is associated with the aforementioned yellowish flecks.
    • Vitreous base excavations represent lesions of similar shape, size, and orientations as lattice lesions having a uniform reddish base and located within the vitreous base.
    • Pigmentary degeneration is a term that most likely represents lattice lesions with prominent but variable pigmentary changes, including clumps of pigment sometimes heavily scattered at the base of lattice lesions and demarcation lines circumscribing cuffs of subretinal fluid.
    • When retinal thinning and pigmentary disturbances are found along retinal vessels, these lattice lesions are referred to as radial perivascular chorioretinal degeneration and are classic findings in Wagner and Stickler disease, a familial vitreoretinal degenerative syndrome.
  • Clinical examination
  • Identification of lattice lesions depends largely upon the experience of the examiner and the method of examination used.
  • The most convenient and frequently used method of examination to detect lattice is with binocular indirect ophthalmoscopy with scleral depression (indentation).
  • Slit lamp examination with a Goldmann contact lens is used less frequently. This method allows for high magnification of the lattice lesions and the associated vitreoretinal relationships, but evaluation with scleral depression, a critical element of the peripheral examination, becomes technically difficult when using a contact lens.
  • Clinical course
    • Lattice lesions are believed to develop early in one's lifetime with minimal progression thereafter. Associated features, such as crisscrossing sclerotic vessels, pigmentation, and atrophic retinal holes, may subsequently develop.
    • Retinal detachment is a relatively rare complication of lattice degeneration ( <1% of patients with lattice degeneration) but is associated with as many as 40% of all rhegmatogenous retinal detachments.
    • Retinal detachments caused by lattice degeneration occur most commonly by a tractional tear at the cuff or posterior margin of the lattice lesion or less commonly by means of an atrophic hole within the zone of lattice.
    • Tractional tears located at the margin of lattice account for 55-70% of retinal detachments in lattice degeneration and are the result of a posterior vitreous detachment.
      • These patients are predominantly older than 50 years, and only 40% of such eyes are myopic.
      • An acute posterior vitreous detachment complicated by retinal tear formation usually is signaled by the complaint of new-onset floaters and/or flashes and the presence of preretinal or vitreous hemorrhage. Patients with these complaints constitute a true ophthalmologic emergency and need urgent ophthalmic examination.
      • Tractional lattice-related detachments typically are supertemporal and not associated with demarcation lines. Surgical repair is successful in 90% of such cases.
    • Atrophic holes account for 30-45% of retinal detachments in lattice degeneration.
      • Seventy percent occur in patients younger than 40 years, and 70% of these detachments occur in myopic eyes.
      • The posterior hyaloid gel usually is attached excluding a tractional mechanism. These detachments are typically inferior, occur slowly, and demonstrate demarcation lines on examination resulting from the slow progressive accumulation of subretinal fluid.
      • A 98-100% success rate exists in repairing such detachments with an excellent visual prognosis.

Causes

See Pathophysiology.

More on Lattice Degeneration

Overview: Lattice Degeneration
Differential Diagnoses & Workup: Lattice Degeneration
Treatment & Medication: Lattice Degeneration
Follow-up: Lattice Degeneration
Multimedia: Lattice Degeneration
References

References

  1. Avitabile T, Bonfiglio V, Reibaldi M, et al. Prophylactic treatment of the fellow eye of patients with retinal detachment: a retrospective study. Graefes Arch Clin Exp Ophthalmol. Mar 2004;242(3):191-6. [Medline].

  2. Byer NE. Long-term natural history of lattice degeneration of the retina. Ophthalmology. Sep 1989;96(9):1396-401; discussion 1401-2. [Medline].

  3. Byer NE. Lattice degeneration of the retina. Surv Ophthalmol. Jan-Feb 1979;23(4):213-48. [Medline].

  4. Edwards AO, Robertson JE Jr. Hereditary vitreoretinal degenerations. In: Ryan SJ, ed. Retina. 3rd ed. St Louis, Mo: Mosby;. 2001: 482-98.

  5. Folk JC, Arrindell EL, Klugman MR. The fellow eye of patients with phakic lattice retinal detachment. Ophthalmology. Jan 1989;96(1):72-9. [Medline].

  6. Foos RY, Simons KB. Vitreous in lattice degeneration of retina. Ophthalmology. May 1984;91(5):452-7. [Medline].

  7. Gonzales CR, Gupta A, Schwartz SD, Kreiger AE. The fellow eye of patients with phakic rhegmatogenous retinal detachment from atrophic holes of lattice degeneration without posterior vitreous detachment. Br J Ophthalmol. Nov 2004;88(11):1400-2. [Medline].

  8. Lewis H. Peripheral retinal degenerations and the risk of retinal detachment. Am J Ophthalmol. Jul 2003;136(1):155-60. [Medline].

  9. Straatsma BR, Zeegen PD, Foos RY, et al. Lattice degeneration of the retina. XXX Edward Jackson Memorial Lecture. Am J Ophthalmol. May 1974;77(5):619-49. [Medline].

  10. Wilkinson C. Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment. Cochrane Database Syst Rev. 2005;CD003170. [Medline].

  11. Wilkinson CP. Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration. Ophthalmology. Jan 2000;107(1):12-5; discussion 15-8. [Medline].

Further Reading

Keywords

snail-track degeneration, palisades, etat givre, radial perivascular chorioretinal degeneration, equatorial degeneration, Milky way–like degeneration, vitreous base excavation

Contributor Information and Disclosures

Author

David Sarraf, MD, Assistant Clinical Professor of Ophthalmology, Jules Stein Eye Institute, University of California at Los Angeles, Greater Los Angeles Veterans Affairs Healthcare System
David Sarraf, MD is a member of the following medical societies: American Academy of Ophthalmology and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Coauthor(s)

Stanley M Saulny, MD, Consulting Staff, Department of Ophthalmology, Ophthalmology Associates of the Valley
Stanley M Saulny, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Writers Association, and American Society of Cataract and Refractive Surgery
Disclosure: Nothing to disclose.

Medical Editor

Vytautas A Pakainis, MD, Chief of Ophthalmology, Dorn Veterans Administration Medical Center, Professor of Ophthalmology, Ophthalmology, University of South Carolina School of Medicine
Vytautas A Pakainis, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and South Carolina Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Steve Charles, MD, Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine
Steve Charles, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Club Jules Gonin, Macula Society, and Retina Society
Disclosure: Alcon Laboratories Consulting fee Consulting; OptiMedica Ownership interest Consulting

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.